GB Pharma

GB Pharma is a Milan-based, full-service CRO that has evolved from a clinical trials provider into a global, multi-country partner offering integrated services in pharmacovigilance, regulatory affairs, and clinical research. The company leverages a flexible, partnership-driven business model to deliver cost-optimized, compliant solutions for a diverse client base, including those in rare diseases. With over 25 years of experience and a focus on operational excellence under certified standards (GxP, ISO 13485), GB Pharma positions itself as a strategic partner for navigating complex regulatory landscapes.

Integrated service methodology and certified operational processes (GxP, ISO 13485) for pharmacovigilance, regulatory affairs, and clinical research, offering tailored, compliance-driven solutions.

GB Pharma competes in a fragmented CRO market against large multinational firms (e.g., IQVIA, ICON) with vast resources and global footprints, as well as numerous small-to-mid-sized regional CROs. It differentiates through a partnership model, integrated service offerings, and a focus on personalized, expert support in complex regulatory areas like pharmacovigilance.